Saenger Bradley

Saenger Bradley is listed in filings as Chief Financial Officer at Tonix Pharmaceuticals Holding Corp.. This profile follows SEC Form 4 activity through Feb 26, 2026, including 5 public disclosures. Recent filings connect the profile to Tonix Pharmaceuticals Holding Corp. (TNXP). The current snapshot covers public activity from Feb 27, 2025 to Feb 26, 2026. Reported amounts are shown as $696.8K to $259.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.